| abstract |
The present invention relates to pharmaceutical compositions comprising pyridinylidene hydrazone derivatives and their uses in the treatment or prevention of neurological and/or neurodegenerative disorders and/or diseases such as, e.g., Alzheimer's disease. Down's syndrome, Hereditary cerebral hemorrhage with amyloidosis Dutch type, Parkinson's disease, ALS (amyotrophic lateral sclerosis). Creutzfeldt-Jacob disease, Huntington's disease, HIV- related dementia, Lewis body dementia and motor neuropathy. |